The Effect of Long-Term Simultaneous Therapy with Salbutamol and Budesonide on Bronchial Reactivity and Serum ECP Level in Asthmatics

Z. Siergiejko, Z. Ziętkowski, S. Chyrek-Borowska
{"title":"The Effect of Long-Term Simultaneous Therapy with Salbutamol and Budesonide on Bronchial Reactivity and Serum ECP Level in Asthmatics","authors":"Z. Siergiejko, Z. Ziętkowski, S. Chyrek-Borowska","doi":"10.1089/JAM.1996.9.527","DOIUrl":null,"url":null,"abstract":"ABSTRACT The effects of 20 weeks of regular application of salbutamol, in comparatively high doses, on asthma symptoms, spirometry, bronchial reactivity, and the serum ECP level in asthmatics, who took inhaled corticosteroids, were studied. The studies were carried out on 20 nonsmoking, mild or moderate, nonallergic patients with stable asthma, treated regularly with inhaled corticosteroids and a β2-agonist if required. After a 1-week run-in period the patients continued the inhalations of corticosteroids and took, on a fixed schedule, 800 μg of salbutamol daily and more on demand. Examinations of the patients and spirometry were performed every 2 weeks. Before and after the treatment, bronchial reactivity to histamine was tested and blood samples for ECP determination were taken. The symptom score, morning and evening PEF, and daily number of β2-agonist doses, taken on demand, were recorded on their diary cards. Small increases in the morning PEF and FEF25–75 (p < 0.05) were observed before the end of th...","PeriodicalId":14879,"journal":{"name":"Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung","volume":"76 1","pages":"527-536"},"PeriodicalIF":0.0000,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/JAM.1996.9.527","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ABSTRACT The effects of 20 weeks of regular application of salbutamol, in comparatively high doses, on asthma symptoms, spirometry, bronchial reactivity, and the serum ECP level in asthmatics, who took inhaled corticosteroids, were studied. The studies were carried out on 20 nonsmoking, mild or moderate, nonallergic patients with stable asthma, treated regularly with inhaled corticosteroids and a β2-agonist if required. After a 1-week run-in period the patients continued the inhalations of corticosteroids and took, on a fixed schedule, 800 μg of salbutamol daily and more on demand. Examinations of the patients and spirometry were performed every 2 weeks. Before and after the treatment, bronchial reactivity to histamine was tested and blood samples for ECP determination were taken. The symptom score, morning and evening PEF, and daily number of β2-agonist doses, taken on demand, were recorded on their diary cards. Small increases in the morning PEF and FEF25–75 (p < 0.05) were observed before the end of th...
沙丁胺醇和布地奈德长期同时治疗对哮喘患者支气管反应性和血清ECP水平的影响
本研究研究了吸入皮质类固醇的哮喘患者,定期大剂量应用沙丁胺醇20周后对哮喘症状、肺活量测定、支气管反应性和血清ECP水平的影响。研究对象为20名不吸烟、轻度或中度、非过敏的稳定哮喘患者,定期接受吸入皮质类固醇治疗,必要时使用β2激动剂。经过一周的磨合期后,患者继续吸入皮质类固醇,并按固定时间表每天服用800 μg沙丁胺醇,并根据需要服用更多。每2周对患者进行检查和肺活量测定。治疗前后分别检测支气管对组胺的反应性,并采血测定ECP。症状评分、早晚PEF、每日β2激动剂剂量(按需服用)记录在日记卡上。早晨PEF和FEF25-75在治疗结束前有小幅升高(p < 0.05)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信